Citations for
1ADAM29, ADAM7
Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanoma.
Wei X, Moncada-Pazos A, Cal S, Soria-Valles C, Gartner J, Rudloff U, Lin JC; NISC Comparative Sequencing Program, Rosenberg SA, López-Otín C, Samuels Y.
Hum Mutat 32(6):E2148-75. doi: 10.1002/humu.21477. Epub 2011 Feb 24. 2011
2ADAM29, LPL
IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.
Maloum K, Settegrana C, Chapiro E, Cazin B, Leprêtre S, Delmer A, Leporrier M, Dreyfus B, Tournilhac O, Mahe B, Nguyen-Khac F, Lesty C, Davi F, Merle-Béral H.
Ann Hematol 88(12):1215-21. Epub 2009 Apr 2. 2009
3ADAM29
The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia.
Oppezzo P, Vasconcelos Y, Settegrana C, Jeannel D, Vuillier F, Legarff-Tavernier M, Kimura EY, Bechet S, Dumas G, Brissard M, Merle-Béral H, Yamamoto M, Dighiero G, Davi F; French Cooperative Group on CLL.
Blood 106(2):650-7. Epub 2005 Mar 31. 2005
4ADAM29
Molecular cloning and mapping of a novel ADAM gene (ADAM29) to human chromosome 4.
Xu R, Cai J, Xu T, Zhou W, Ying B, Deng K, Zhao S, Li C.
Genomics 62(3):537-9 1999
5ADAM29, ADAM30
Isolation of two novel metalloproteinase-disintegrin (ADAM) cDNAs that show testis-specific gene expression.
Cerretti DP, DuBose RF, Black RA, Nelson N.
Biochem Biophys Res Commun 263(3):810-5 1999